Pay-it-forward gonorrhea testing among men who have sex with men: The PIONEER pragmatic randomized controlled trial

对男男性行为者进行前额淋病检测:PIONEER 实用随机对照试验

基本信息

  • 批准号:
    10185281
  • 负责人:
  • 金额:
    $ 63.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-03-19 至 2026-02-28
  • 项目状态:
    未结题

项目摘要

Most men who have sex with men (MSM) do not receive gonorrhea testing, contributing to delayed treatment and potentially amplifying antimicrobial resistance. Poor test uptake is often related to costs associated with STD testing and minimal community engagement. We have developed a pay-it-forward intervention to enhance gonorrhea testing among MSM. Pay-it-forward involves an individual receiving a gift (in this case, a gonorrhea test) and then be provided the opportunity to give a gift (in this case, money to support gonorrhea testing) to another person. Pay-it-forward is an example of upstream reciprocity theory suggesting that people who are helped by someone feel a “warm glow” that makes them more likely to help others. Pay-it-forward has been used to encourage people to donate something to another person. But in this study, we will test the effectiveness of two levels of implementation strategies based on upstream reciprocity to motivate gift recipients to get tested for gonorrhea. Specifically, we will compare a standard pay-it-forward implementation strategy with minimal encouragement to get tested and a community-engaged pay-it-forward strategy alongside a control arm in which men pay for their own STD test. Our pilot randomized controlled trial in two cities found that pay-it-forward substantially increased gonorrhea testing compared to the control arm (56% in the pay-it-forward arm, 18% in control arm). Our pilot data also suggests that greater MSM community engagement (e.g., MSM participatory activities to create testing messages) increases donations to the program, reinforcing the hypothesis that a community-engaged implementation strategy can activate upstream reciprocity. Intensified testing could also decrease antibiotic resistance. Building on our UNC Project-China research infrastructure in China, we propose the Pay-It-forward gONorrhEa tEsting RCT (PIONEER). The study has the following specific aims: (1) to use a three-arm cluster randomized controlled trial to compare gonorrhea testing uptake in a standard pay-it-forward strategy arm, a community-engaged pay-it-forward strategy arm, and a control arm reflecting current practice; (2) to determine mechanisms through which different pay-it-forward strategies activate upstream reciprocity to influence gonorrhea testing and donations; (3) to examine the impact of enhanced gonorrhea testing on the development of gonorrhea resistance. Based on our prior work, we hypothesize that a community-engaged pay-it-forward strategy will increase gonorrhea test uptake rates compared to the standard strategy, and that pay-it-forward in general is superior to the current practice of paid testing. Our proposal is innovative because it provides a new financing mechanism to support gonorrhea testing, tests implementation strategies to enhance the effectiveness of this mechanism, and will provide more detailed information about the relationship between increasing testing and the development of antimicrobial resistance. This proposal has significant public health implications for the delivery of sexual minority health services in low and middle-income countries and is aligned with the mission of NIAID.
大多数与男性发生性关系(MSM)的男性未接受淋病测试,导致延迟治疗 并可能扩大抗菌素的耐药性。 性病测试和最少的社区参与。 增强MSM的淋病测试。 淋病测试)和该证明是送礼物的机会(在这种情况下,资金支持淋病 对另一个人进行测试。 谁会受到某人的帮助,他们会感到“温暖的光芒”,使主题可能会帮助他人。 被用来鼓励人们向他人捐款。 基于上游互惠的两个层次的含义策略的有效性以激发礼物 接受淋病的接收者,我们将比较标准的付费效果。 策略最少鼓励接受测试和社区参与的付费策略 除了控制剧院自己的性病测试的控制臂。 城市发现,付费额会大大增加了对控制臂的淋病测试(56% 我们的飞行员数据ALSOSO的付费臂,有18% 参与度(例如,MSM参与性活动以创建测试消息)增加了对 计划,加强了社区参与实施方式可以激活上游的假设 互惠的测试可能会降低我们的UNC Project-Chana。 中国的研究基础设施,我们提出了付费促销的淋病测试RCT(Pioneer) 研究具有以下具体目的:(1)使用三臂群集随机对照试验进行比较 淋病测试在标准付款策略臂中的吸收 策略部门和一个反映当前实践的控制臂; 不同的付费策略会激活上游互惠,以影响淋病测试和捐赠; (3)检查增强的淋病测试对基于淋病的发展的影响。 在我们的先前工作中,我们假设由共同参与的付费策略将增加淋病 与标准策略相比,测试吸收率,并且总体上的付费优势优于。 当前的付费测试实践。 支持淋病测试,测试实施策略以增强该机制的有效性, 并将主要有关增加测试与您之间关系的更多详细信息 抗菌素抵抗的发展对交付具有重大的公共卫生影响 低收入和中等收入国家的性少数民族卫生服务,与Niaid的使命保持一致。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph David Tucker其他文献

Joseph David Tucker的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph David Tucker', 18)}}的其他基金

Pay-it-forward gonorrhea testing among men who have sex with men: The PIONEER pragmatic randomized controlled trial
对男男性行为者进行前额淋病检测:PIONEER 实用随机对照试验
  • 批准号:
    10374894
  • 财政年份:
    2021
  • 资助金额:
    $ 63.88万
  • 项目类别:
Mentoring Multidisciplinary Global HIV Patient-Oriented Research
指导多学科全球艾滋病毒患者导向研究
  • 批准号:
    10318098
  • 财政年份:
    2019
  • 资助金额:
    $ 63.88万
  • 项目类别:
Mentoring Multidisciplinary Global HIV Patient-Oriented Research
指导多学科全球艾滋病毒患者导向研究
  • 批准号:
    10540699
  • 财政年份:
    2019
  • 资助金额:
    $ 63.88万
  • 项目类别:
Spurring Innovation in HIV Testing and Linkage: A Crowdsourcing Approach -Diversity Supplement
刺激艾滋病毒检测和联系的创新:众包方法 - 多样性补充
  • 批准号:
    9370061
  • 财政年份:
    2014
  • 资助金额:
    $ 63.88万
  • 项目类别:
Spurring Innovation in HIV Testing and Linkage: A Crowdsourcing Approach
刺激艾滋病毒检测和关联的创新:众包方法
  • 批准号:
    8928045
  • 财政年份:
    2014
  • 资助金额:
    $ 63.88万
  • 项目类别:
UNC-South China STD Research Training Conference
北卡罗来纳大学-华南性病研究培训会
  • 批准号:
    8399824
  • 财政年份:
    2012
  • 资助金额:
    $ 63.88万
  • 项目类别:
Syphilis social epidemiology in the People's Republic of China
中华人民共和国梅毒社会流行病学
  • 批准号:
    8101175
  • 财政年份:
    2010
  • 资助金额:
    $ 63.88万
  • 项目类别:
Syphilis social epidemiology in the People's Republic of China
中华人民共和国梅毒社会流行病学
  • 批准号:
    8452750
  • 财政年份:
    2010
  • 资助金额:
    $ 63.88万
  • 项目类别:
Syphilis social epidemiology in the People's Republic of China
中华人民共和国梅毒社会流行病学
  • 批准号:
    8531366
  • 财政年份:
    2010
  • 资助金额:
    $ 63.88万
  • 项目类别:
Syphilis social epidemiology in the People's Republic of China
中华人民共和国梅毒社会流行病学
  • 批准号:
    8284349
  • 财政年份:
    2010
  • 资助金额:
    $ 63.88万
  • 项目类别:

相似国自然基金

基于真菌的跨界群体感应干扰对水环境抗生素抗性基因传播的影响及调控研究
  • 批准号:
    42307159
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
可溶态生物炭对抗生素抗性基因在水土环境中迁移与水平转移的影响及机制
  • 批准号:
    42307468
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
熏蒸结合动物堆肥对土壤-蔬菜系统抗生素抗性基因的影响机制
  • 批准号:
    42307033
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
人工补给对地下水抗生素抗性组与病原菌的影响及调控机制
  • 批准号:
    42377392
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
典型非抗生素类药物对活性污泥多质粒介导下抗生素抗性基因水平转移的影响机制研究
  • 批准号:
    42307529
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters
研究泌尿道致病性大肠杆菌氟喹诺酮类持续存在的代谢和 DNA 损伤修复
  • 批准号:
    10747651
  • 财政年份:
    2023
  • 资助金额:
    $ 63.88万
  • 项目类别:
Commercialization Readiness Pilot (CRP) program support for: Direct-from-specimen identification of pathogens common in endocarditis
商业化准备试点 (CRP) 计划支持: 直接从样本鉴定心内膜炎常见病原体
  • 批准号:
    10758417
  • 财政年份:
    2023
  • 资助金额:
    $ 63.88万
  • 项目类别:
A Randomized Pilot and Feasibility Study of a cultuRE-Directed approach to Urinary traCT Infection symptoms in older womeN: a mixed methods evaluation - the REDUCTION trial
针对老年女性尿路感染症状的文化导向方法的随机试验和可行性研究:混合方法评估 - REDUCTION 试验
  • 批准号:
    10586250
  • 财政年份:
    2023
  • 资助金额:
    $ 63.88万
  • 项目类别:
Human Immunomics & Trained Immunity in Persistent Candidemia
人类免疫组学
  • 批准号:
    10551710
  • 财政年份:
    2023
  • 资助金额:
    $ 63.88万
  • 项目类别:
An Integrated Catheter Dressing for Early Detection of Catheter-related Bloodstream Infections
用于早期检测导管相关血流感染的集成导管敷料
  • 批准号:
    10647072
  • 财政年份:
    2023
  • 资助金额:
    $ 63.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了